Literature DB >> 21548877

Thioridazine: the good and the bad.

R H Thanacoody1.   

Abstract

Thioridazine is a phenothiazine drug which has previously been extensively used for its antipsychotic properties as it is associated with a low risk of extra-pyramidal side-effects. There is good evidence to suggest that, in common with other phenothiazine drugs, thioridazine has important anti-microbial activity and is a potential candidate for development as an anti-microbial drug against multi-resistant organisms, including drug-resistant strains of M. tuberculosis. The clinical pharmacology and toxicity profile of thioridazine are reviewed in this article and the implications for future drug development along with the patent are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21548877     DOI: 10.2174/157489111796064588

Source DB:  PubMed          Journal:  Recent Pat Antiinfect Drug Discov        ISSN: 1574-891X


  10 in total

1.  Reduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.

Authors:  Noton K Dutta; Michael L Pinn; Petros C Karakousis
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

2.  Thioridazine lacks bactericidal activity in an animal model of extracellular tuberculosis.

Authors:  Noton K Dutta; Michael L Pinn; Ming Zhao; Michelle A Rudek; Petros C Karakousis
Journal:  J Antimicrob Chemother       Date:  2013-03-05       Impact factor: 5.790

3.  Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines.

Authors:  Lici A Schurig-Briccio; Takahiro Yano; Harvey Rubin; Robert B Gennis
Journal:  Biochim Biophys Acta       Date:  2014-04-05

4.  Effect of thioridazine on erythrocytes.

Authors:  Elisabeth Lang; Paola Modicano; Markus Arnold; Rosi Bissinger; Caterina Faggio; Majed Abed; Florian Lang
Journal:  Toxins (Basel)       Date:  2013-10-23       Impact factor: 4.546

5.  MALT1 promotes melanoma progression through JNK/c-Jun signaling.

Authors:  Y Wang; G Zhang; J Jin; S Degan; Y Tameze; J Y Zhang
Journal:  Oncogenesis       Date:  2017-07-31       Impact factor: 7.485

Review 6.  Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action.

Authors:  Leonard Amaral; Miguel Viveiros
Journal:  Antibiotics (Basel)       Date:  2017-01-14

Review 7.  Pharmacogenomic Biomarkers and Their Applications in Psychiatry.

Authors:  Heejin Kam; Hotcherl Jeong
Journal:  Genes (Basel)       Date:  2020-11-30       Impact factor: 4.096

8.  Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping.

Authors:  Carolina Alves Nicolau; Alyson Prorock; Yongde Bao; Ana Gisele da Costa Neves-Ferreira; Richard Hemmi Valente; Jay William Fox
Journal:  Toxins (Basel)       Date:  2018-02-06       Impact factor: 4.546

9.  Thioridazine Induces Cardiotoxicity via Reactive Oxygen Species-Mediated hERG Channel Deficiency and L-Type Calcium Channel Activation.

Authors:  Yan Liu; Xueqi Xu; Yuhao Zhang; Mingzhu Li; Jiamengyi Guo; Caichuan Yan; Fang Wang; Yuexin Li; Yunqi Ding; Baoxin Li; Pan Fan
Journal:  Oxid Med Cell Longev       Date:  2020-01-22       Impact factor: 6.543

Review 10.  Repurposing Antipsychotics for Cancer Treatment.

Authors:  Nikolaos Vlachos; Marios Lampros; Spyridon Voulgaris; George A Alexiou
Journal:  Biomedicines       Date:  2021-11-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.